VelaVigo Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 80

Employees

  • Latest Deal Type
  • Early Stage VC

  • Latest Deal Amount
  • $60M

  • Investors
  • 16

VelaVigo General Information

Description

Manufacturer of innovative biologic therapeutics designed to address unmet medical needs in oncology, autoimmune disorders, and other serious diseases. The company offers novel antibody-based medicines, including multispecific antibodies and antibody-drug conjugates, supported by proprietary drug discovery and translational research platforms, enabling biopharmaceutical advancement across discovery, clinical development, and commercialization for patients with serious diseases.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Building 1, Number 215, Fute South Road
  • Pudong New Area
  • Shanghai, 200131
  • China
+86 021
Primary Industry
Biotechnology
Other Industries
Drug Discovery
Vertical(s)
Corporate Office
  • Building 1, Number 215, Fute South Road
  • Pudong New Area
  • Shanghai, 200131
  • China
+86 021

VelaVigo Timeline

2023202420252026
Financing RoundCaptured Employee CountEstimated Employee Growth

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

VelaVigo Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Early Stage VC 27-Jul-2025 $60M Completed Generating Revenue
2. Early Stage VC 31-Dec-2024 Completed Generating Revenue
1. Seed Round 15-Nov-2021 $50M $50M Completed Startup
To view VelaVigo’s complete valuation and funding history, request access »

VelaVigo Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

VelaVigo Investors (16)

Investor Name Investor Type Holding Investor Since Participating Rounds
Everest VC Venture Capital Minority
Hankang Capital Growth/Expansion Minority
Northern Light Venture Capital Venture Capital Minority
Shanghai Lingang Economic Development Limited Partner Minority
Shunwei Capital Venture Capital Minority
You’re viewing 5 of 16 investors. Get the full list »

VelaVigo FAQs

  • When was VelaVigo founded?

    VelaVigo was founded in 2021.

  • Where is VelaVigo headquartered?

    VelaVigo is headquartered in Shanghai, China.

  • What is the size of VelaVigo?

    VelaVigo has 80 total employees.

  • What industry is VelaVigo in?

    VelaVigo’s primary industry is Biotechnology.

  • Is VelaVigo a private or public company?

    VelaVigo is a Private company.

  • What is VelaVigo’s current revenue?

    The current revenue for VelaVigo is .

  • How much funding has VelaVigo raised over time?

    VelaVigo has raised $160M.

  • Who are VelaVigo’s investors?

    Everest VC, Hankang Capital, Northern Light Venture Capital, Shanghai Lingang Economic Development, and Shunwei Capital are 5 of 16 investors who have invested in VelaVigo.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process